Paolo Ambrosini
Paolo Ambrosini publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Immunology, on topics such as Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Radiomics and Machine Learning in Medical Imaging.
- World rank
- #3,342,849 of 7,710,434 ranked researchers
- Rank in Italy
- #113,230 of 242,206
- Works
- 43
- Citations
- 324
- Citations per work
- 7.5
What does Paolo Ambrosini research?
Paolo Ambrosini's work is mostly in Medicine (64%), Immunology and Microbiology (10%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2864.0%
- Medicine2864.0%
- Everything else1023.2%
- Life Sciences612.8%
- 1Oncology26% of their works
- 2Pulmonary and Respiratory Medicine25% of their works
- 3Immunology10% of their works
- 4Radiology, Nuclear Medicine and Imaging7% of their works
- 5Surgery6% of their works
- 6Molecular Biology3% of their works
Research topics
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Treatments and Mutations
- Radiomics and Machine Learning in Medical Imaging
- Lung Cancer Research Studies
- Psoriasis: Treatment and Pathogenesis
- Lung Cancer Diagnosis and Treatment
- Occupational and environmental lung diseases
- Immune Cell Function and Interaction
Which keywords describe Paolo Ambrosini's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Chemotherapy, Immunotherapy, ALK Inhibitors and EGFR Mutations.
- Natural Killer Cells
- TH17 Cells
- Lung Cancer
- CT Screening
- Small-Cell Lung Cancer
- Radiomics
- EGFR Mutations
- Immunotherapy
- PD-1 and PD-L1
- Targeted Therapy
- Clinical Trials
- Immune Checkpoint Blockade
- Chemotherapy
- ALK Inhibitors
- Medical Imaging
- Genomic Profiles
- BAP1 mutations
- IL-17
- Malignant Pleural Mesothelioma
- NK Cell Recognition
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Clinical Trials152 topics
- Targeted Therapy152 topics
- Immune Checkpoint Blockade141 topic
- PD-1 and PD-L1141 topic
- Chemotherapy102 topics
- Immunotherapy102 topics
- ALK Inhibitors91 topic
- EGFR Mutations91 topic
- Medical Imaging91 topic
- Radiomics91 topic
- Genomic Profiles61 topic
- Small-Cell Lung Cancer61 topic
- BAP1 mutations41 topic
- CT Screening41 topic
- IL-1741 topic
- Lung Cancer41 topic
- Malignant Pleural Mesothelioma41 topic
- TH17 Cells41 topic
- NK Cell Recognition31 topic
- Natural Killer Cells31 topic
Where does Paolo Ambrosini work?
Paolo Ambrosini's main affiliation in the publication record is Fondazione IRCCS Istituto Nazionale dei Tumori, Italy.
How many publications and citations does Paolo Ambrosini have?
OpenAlex counts 43 works and 324 citations for Paolo Ambrosini, an h-index of 8, ranking #3,342,849 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Paolo Ambrosini. Posts are plain text and can be reported.